Stay updated with breaking news from Chief Technical Operations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Moderna, Inc. / Key word(s): Agreement Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicin...
DGAP-News: Moderna, Inc. / Key word(s): Agreement Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years 16.02.2022 / 08:35 The issuer is solely responsible for the content of this announcement. MODERNA AND ROVI EXPAND LONG-TERM COLLABORATIO...
CAMBRIDGE, MA / ACCESSWIRE / February 9, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Juan Andres, Chief Technical
Leading RNA intereference (RNAi) therapeutics company, Alnylam, has been welcomed as the latest partner in the Medicines Manufacturing Innovation Centre, to transform the manufacturing process of oligonucleotide therapies. - News - PharmaTimes
/PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the...